2020
DOI: 10.3390/ijms21103479
|View full text |Cite
|
Sign up to set email alerts
|

Novel Medicinal Mushroom Blend as a Promising Supplement in Integrative Oncology: A Multi-Tiered Study using 4T1 Triple-Negative Mouse Breast Cancer Model

Abstract: Although medicinal mushroom extracts have been proposed as promising anti-cancer agents, their precise impacts on metastatic breast cancer are still to be clarified. For this purpose, the present study exploited the effect of a novel medicinal mushroom blend, namely Micotherapy U-care, in a 4T1 triple-negative mouse breast cancer model. Mice were orally administered with Micotherapy U-care, consisting of a mixture of Agaricus blazei, Ophiocordyceps sinensis, Ganoderma lucidum, Grifola frondosa, and Lentinula e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
25
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
8

Relationship

2
6

Authors

Journals

citations
Cited by 23 publications
(26 citation statements)
references
References 77 publications
1
25
0
Order By: Relevance
“…For the syngeneic tumor-bearing mice (4T1 and 4T1 M. U-care) generation see the work in [36]. The syngeneic tumor-bearing mice (4T1 and 4T1 M. U-care) were generated by injecting 1 × 10 6 of the 4T1 cells into the nape of the neck of the female Balb/C mice.…”
Section: Animals and Experimental Planmentioning
confidence: 99%
See 2 more Smart Citations
“…For the syngeneic tumor-bearing mice (4T1 and 4T1 M. U-care) generation see the work in [36]. The syngeneic tumor-bearing mice (4T1 and 4T1 M. U-care) were generated by injecting 1 × 10 6 of the 4T1 cells into the nape of the neck of the female Balb/C mice.…”
Section: Animals and Experimental Planmentioning
confidence: 99%
“…Immunohistochemical labeling extent evaluation was previously described in detail [36]. The optical density (OD), intended as immunohistochemical intensity, was assessed in 30 cells/section per six slides/mouse.…”
Section: Dilutionmentioning
confidence: 99%
See 1 more Smart Citation
“…A mushroom mixture named as Micotherapy U-care consisted of G. lucidum, Lentinula edodes, Agaricus blazei, Ophiocordyceps sinensis, and Grifola frondosa was orally administered in mice implanted with triple-negative breast cancer. The results showed reduced pulmonary metastases density as well as decreased expression of interleukin-6, NOS, and COX-2 [ 53 ]. In another study, the anticancer effect of β-glucans along with radiation therapy was evaluated against lung cancer.…”
Section: Medicinal Properties Of Mushrooms Native To North Americamentioning
confidence: 99%
“…Over the past two decades, medicinal mushroom exopolysaccharides (EPS) and endopolysaccharide (ENS) have been increasingly exploited for human benefits including clinical trials [ 1 ], neurological protection [ 2 ], potent in vitro biological activities [ 3 ], chicken patty [ 4 ], anti-oral cancer [ 5 ], and breast cancer models [ 6 ]; however, there is still limited development as yet on their commercial use by the aquaculture industry. Development and exploitation of medicinal mushroom products has significant potential to improve farmed fish health, where appropriate innovation in fish feed and formulation potentially offers safe, affordable and future intensive sustainability needs [ 7 , 8 , 9 ].…”
Section: Introductionmentioning
confidence: 99%